Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Dec;7(6):463-70.

An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine

K Kiura  1 , T Ohnoshi, H Ueoka, N Takigawa, M Tabata, Y Segawa, T Shibayama, I Kimura
Affiliations
  • PMID: 1337430

An adriamycin-resistant subline is more sensitive than the parent human small cell lung cancer cell line to lonidamine

K Kiura et al. Anticancer Drug Des. 1992 Dec.

Abstract

Lonidamine, a unique new type of anticancer agent, has been shown to exert marginal activity in patients with resistant small cell lung cancer. We have assessed cytotoxic activity using seven human small cell lung cancer cell lines and the drug resistant small cell lung cancer sublines, Adriamycin-resistant SBC-3/ADM100, etoposide-resistant SBC-3/ETP and cisplatin-resistant SBC-3/CDDP. Although lonidamine had only a minimal activity in seven human small cell lung cancer cell lines, SBC-3/ADM100 cells were more sensitive to lonidamine than the parent SBC-3 cells to a 1.6-fold extent in terms of IC50. SBC-3/CDDP and SBC-3/ETP had no cross-resistance to lonidamine at all. These observations may be of potential clinical significance in treating small cell lung cancer.

PubMed Disclaimer

LinkOut - more resources